Hematologic Neoplasms - Therapy
Research News and Information

Monday, November 23, 2009

Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.

30 Aug 2009 In this retrospective monocenter study, we analyzed the outcomes of 130 adult hematological patients who developed a proven (n = 23), probable (n = 71), and possible (n = 36) invasive aspergillosis (IA) in a 13-year period. Forty-nine patients (38%) ... Read more...

Ocular findings after allogeneic hematopoietic stem cell transplantation.

30 Aug 2009 OBJECTIVE: To study the incidence, causes, and outcome of major ocular complications in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). DESIGN: Retrospective, noncomparative, observational clinical study. PARTICIPANTS: ... Read more...

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.

25 Aug 2009 Graft-versus-host disease (GVHD) is a significant complication of allogeneic stem cell transplantation (alloSCT). The proteasome inhibitor bortezomib has immunomodulatory properties of potential benefit for GVHD control. We undertook a phase 1 trial ... Read more...

Latest indexed articles for 'Hematologic Neoplasms - Therapy'

These are the very latest articles for this heading:

• Pediatric hematology oncology in Brazil. 30 Oct 2009
• Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can. 15 Sep 2009
• Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. 30 Aug 2009
• Ocular findings after allogeneic hematopoietic stem cell transplantation. 30 Aug 2009
• Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. 25 Aug 2009
• Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. 16 Aug 2009
• Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Aug 2009
• Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. Aug 2009
• The role of natalizumab in hematopoietic stem cell mobilization. 30 Jul 2009
• HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. 30 Jul 2009
• Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. 30 Jul 2009
• Neoplastic hematopathology. Preface. 30 Jul 2009
• The microenvironment in mature B-cell malignancies: a target for new treatment strategies. 25 Jul 2009
• Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. 29 Jun 2009
• Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation. 29 Jun 2009
• Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation. 29 Jun 2009
• Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. 29 Jun 2009
• Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. 29 Jun 2009
• Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. 29 Jun 2009
• Recent advances in antifungal prevention and treatment. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Hematologic Neoplasms'

Definition: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Descriptor UI: D019337

Alternative terms: Hematologic Neoplasms; Malignancies, Hematologic; Malignancy, Hematologic; Hematological Neoplasms; Hematological Neoplasm; Neoplasm, Hematological; Neoplasms, Hematological; Neoplasms, Hematologic; Hematologic Neoplasm; Neoplasm, Hematologic; Hematological Malignancies; Hematological Malignancy; Malignancies, Hematological; Malignancy, Hematological; Hematologic Malignancy; Hematologic Malignancies; Hematopoietic Neoplasms; Hematopoietic Malignancies; Hematopoietic Malignancy; Malignancies, Hematopoietic; Malignancy, Hematopoietic; Neoplasms, Hematopoietic; Hematopoietic Neoplasm; Neoplasm, Hematopoietic;

Related Mesh Headings: Leukemia; Lymphoma;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.448; C15.378.400;

History Note: 97

Technical Notes: GEN or unspecified only; prefer LEUKEMIA or LYMPHOMA or their specifics; do not use /blood supply /second /secret; DF: HEMATOL NEOPL